MDWDMediWoundMDWD info
$17.57info-5.18%24h
Global rank18584
Market cap$161.98M
Change 7d-
YTD Performance69.76%
SP500 benchmarkOutperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    MediWound (MDWD) Stock Overview

    MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in United States, Europe, and internationally. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. The company also develops EscharEx, which has completed Phase II clinical trials for the debridement of chronic and other hard-to-heal wounds; MW005, which is in phase I/II for the treatment of low-risk basal cell carcinoma. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne, Israel.

    MDWD Stock Information

    Symbol
    MDWD
    Address
    42 Hayarkon StreetYavne, 8122745Israel
    Founded
    -
    Trading hours
    -
    Website
    https://www.mediwound.com
    Country
    🇮🇱 Israel
    Phone Number
    972 7 797 14100

    MediWound (MDWD) Price Chart

    -
    Value:-

    MediWound Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $17.57
    N/A
    Market Cap
    $161.98M
    N/A
    Shares Outstanding
    9.22M
    N/A
    Employees
    83.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    © 2024 Topstocks.org